NeuroSense receives South Korean patent for ALS drug PrimeC Jun 11, 2026 09:02AM
NeuroSense receives Japanese patent for ALS drug candidate PrimeC Jun 9, 2026 09:01AM
NeuroSense reports 65% death risk reduction in ALS trial Feb 18, 2026 09:05AM